Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Cleveland Clinic Journal of Medicine
|
December 3, 2003
Scleroderma: a treatable disease
Joseph H Korn
Current Rheumatology Reports
|
March 14, 2002
Apoptosis and myofibroblasts in the pathogenesis of systemic sclerosis
Eugene Kissin, Joseph H Korn
Rheumatic Diseases Clinics of North America
|
July 5, 2003
Fibrosis in scleroderma
Eugene Y Kissin, Joseph H Korn
Arthritis and Rheumatism
|
June 10, 2003
The role of leukotrienes in alveolitis associated with scleroderma
Robert W Simms, Joseph H Korn
Current Opinion in Rheumatology
|
November 1, 2002
Cytokine directed therapy in scleroderma: rationale, current status, and the future
Robert W Simms, Joseph H Korn
Arthritis and Rheumatism
|
June 4, 2005
Increased expression of type I collagen induced by microfibril-associated glycoprotein 2: novel mechanistic insights into the molecular basis of dermal fibrosis in scleroderma
Raphael Lemaire, Joseph H Korn, J Michael Shipley, et al.
Matrix Biology : Journal of the International Society for Matrix Biology
|
March 8, 2006
Cartilage oligomeric matrix protein is overexpressed by scleroderma dermal fibroblasts
Giuseppina Farina, Raphael Lemaire, Joseph H Korn, et al.
The Journal of Investigative Dermatology
|
December 22, 2004
Fibulin-2 and fibulin-5 alterations in tsk mice associated with disorganized hypodermal elastic fibers and skin tethering
Raphael Lemaire, Joseph H Korn, William P Schiemann, et al.
Arthritis and Rheumatism
|
November 13, 2002
Transforming growth factor beta induces fibroblast fibrillin-1 matrix formation
Eugene Y Kissin, Raphael Lemaire, Joseph H Korn, et al.
Arthritis and Rheumatism
|
March 17, 2004
Mutant fibrillin 1 from tight skin mice increases extracellular matrix incorporation of microfibril-associated glycoprotein 2 and type I collagen
Raphael Lemaire, Guiseppina Farina, Eugene Kissin, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Cleveland Clinic Journal of Medicine
|
December 3, 2003
Scleroderma: a treatable disease
Joseph H Korn
Current Rheumatology Reports
|
March 14, 2002
Apoptosis and myofibroblasts in the pathogenesis of systemic sclerosis
Eugene Kissin, Joseph H Korn
Rheumatic Diseases Clinics of North America
|
July 5, 2003
Fibrosis in scleroderma
Eugene Y Kissin, Joseph H Korn
Arthritis and Rheumatism
|
June 10, 2003
The role of leukotrienes in alveolitis associated with scleroderma
Robert W Simms, Joseph H Korn
Current Opinion in Rheumatology
|
November 1, 2002
Cytokine directed therapy in scleroderma: rationale, current status, and the future
Robert W Simms, Joseph H Korn
Arthritis and Rheumatism
|
June 4, 2005
Increased expression of type I collagen induced by microfibril-associated glycoprotein 2: novel mechanistic insights into the molecular basis of dermal fibrosis in scleroderma
Raphael Lemaire, Joseph H Korn, J Michael Shipley, et al.
Matrix Biology : Journal of the International Society for Matrix Biology
|
March 8, 2006
Cartilage oligomeric matrix protein is overexpressed by scleroderma dermal fibroblasts
Giuseppina Farina, Raphael Lemaire, Joseph H Korn, et al.
The Journal of Investigative Dermatology
|
December 22, 2004
Fibulin-2 and fibulin-5 alterations in tsk mice associated with disorganized hypodermal elastic fibers and skin tethering
Raphael Lemaire, Joseph H Korn, William P Schiemann, et al.
Arthritis and Rheumatism
|
November 13, 2002
Transforming growth factor beta induces fibroblast fibrillin-1 matrix formation
Eugene Y Kissin, Raphael Lemaire, Joseph H Korn, et al.
Arthritis and Rheumatism
|
March 17, 2004
Mutant fibrillin 1 from tight skin mice increases extracellular matrix incorporation of microfibril-associated glycoprotein 2 and type I collagen
Raphael Lemaire, Guiseppina Farina, Eugene Kissin, et al.
Page
of 2